This inventor holds 2 USPTO granted patents. Top assignee: Fujirebio Inc.. Active years: 1995-1996.
Company Filing History:
Years Active: 1995-1996
Title: Miwa Ishihara: Innovator in Cholesterol-Lowering Agents
Introduction
Miwa Ishihara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering agents. With a total of 2 patents, his work has the potential to impact health and wellness positively.
Latest Patents
Ishihara's latest patents include innovative 4-fluorobiphenyl derivatives. These derivatives are characterized by their strong inhibitory effect on HMG-CoA reductase, making them useful as cholesterol-lowering agents. The compounds are designed with specific structural formulas that allow them to function effectively in lipid management.
Career Highlights
Miwa Ishihara is currently employed at Fujirebio Inc., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that address critical health issues related to cholesterol and lipids.
Collaborations
Ishihara collaborates with esteemed colleagues, including Masakatsu Matsumoto and Nobuko Watanabe, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Miwa Ishihara's contributions to the field of pharmaceuticals, particularly in cholesterol-lowering agents, highlight his role as a significant inventor. His ongoing work at Fujirebio Inc. and his collaborations with talented colleagues further emphasize the importance of innovation in healthcare.